Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhisa Furuichi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|December 1, 2012
Translational PK-PD modeling in painAshraf Yassen, Paul Passier, Yasuhisa Furuichi, et al.
Journal of Pharmacological Sciences|August 17, 2010
Sustained analgesic effect of the Rho kinase inhibitor AS1892802 in rat models of chronic painEiji Yoshimi, Hiroko Yamamoto, Yasuhisa Furuichi, et al.
Experimental Neurology|December 16, 2006
Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activatorYasuhisa Furuichi, Masashi Maeda, Nobuya Matsuoka, et al.
Experimental Neurology|May 23, 2006
Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemiaDaisuke Koketsu, Yasuhisa Furuichi, Masashi Maeda, et al.
Brain Research|December 23, 2008
Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke modelMasashi Maeda, Yasuhisa Furuichi, Takahisa Noto, et al.
Journal of Neurotrauma|November 25, 2005
Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonistKayoko Mihara, Toshiaki Aoki, Akira Moriguchi, et al.
Biological & Pharmaceutical Bulletin|February 3, 2007
Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in ratTakahisa Noto, Yasuhisa Furuichi, Masayuki Ishiye, et al.
The Journal of Veterinary Medical Science|September 6, 2006
Temporal and topographic profiles of tissue hypoxia following transient focal cerebral ischemia in ratsTakahisa Noto, Yasuhisa Furuichi, Masayuki Ishiye, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 4, 2003
Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primatesYasuhisa Furuichi, Masashi Maeda, Akira Moriguchi, et al.
Brain Research|February 20, 2003
Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacyYasuhisa Furuichi, Kiyotaka Katsuta, Masashi Maeda, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|December 1, 2012
Translational PK-PD modeling in painAshraf Yassen, Paul Passier, Yasuhisa Furuichi, et al.
Journal of Pharmacological Sciences|August 17, 2010
Sustained analgesic effect of the Rho kinase inhibitor AS1892802 in rat models of chronic painEiji Yoshimi, Hiroko Yamamoto, Yasuhisa Furuichi, et al.
Experimental Neurology|December 16, 2006
Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activatorYasuhisa Furuichi, Masashi Maeda, Nobuya Matsuoka, et al.
Experimental Neurology|May 23, 2006
Increased number of new neurons in the olfactory bulb and hippocampus of adult non-human primates after focal ischemiaDaisuke Koketsu, Yasuhisa Furuichi, Masashi Maeda, et al.
Brain Research|December 23, 2008
Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke modelMasashi Maeda, Yasuhisa Furuichi, Takahisa Noto, et al.
Journal of Neurotrauma|November 25, 2005
Prohemorrhagic and bleeding time activities of recombinant tissue plasminogen activator, heparin, aspirin, and a glycoprotein IIb/IIIa antagonistKayoko Mihara, Toshiaki Aoki, Akira Moriguchi, et al.
Biological & Pharmaceutical Bulletin|February 3, 2007
Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in ratTakahisa Noto, Yasuhisa Furuichi, Masayuki Ishiye, et al.
The Journal of Veterinary Medical Science|September 6, 2006
Temporal and topographic profiles of tissue hypoxia following transient focal cerebral ischemia in ratsTakahisa Noto, Yasuhisa Furuichi, Masayuki Ishiye, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 4, 2003
Tacrolimus, a potential neuroprotective agent, ameliorates ischemic brain damage and neurologic deficits after focal cerebral ischemia in nonhuman primatesYasuhisa Furuichi, Masashi Maeda, Akira Moriguchi, et al.
Brain Research|February 20, 2003
Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacyYasuhisa Furuichi, Kiyotaka Katsuta, Masashi Maeda, et al.
Pageof 2